<PAGE>
December 19, 2000
VIA EDGAR, FACSIMILE AND U.S. MAIL
----------------------------------
Securities and Exchange Commission
Division of Corporate Finance
450 Fifth Street, N.W.
Washington, DC 20549
Re: TheraSense, Inc. Commission File No. 333-47792- Application for
Withdrawal
Ladies and Gentlemen:
Pursuant to Rule 477(a) promulgated under the Securities Act of 1933, as
amended, the undersigned registrant (the "Registrant") hereby applies for an
order granting withdrawal of its Registration Statement on Form S-1, together
with all exhibits thereto, Commission File No. 333-47792 (collectively, the
"Registration Statement"). The Registration Statement was originally filed with
the Securities and Exchange Commission (the "Commission") on October 11, 2000.
At this time, due to the volatility of the public capital markets, the
Registrant has determined not to proceed with the public offering contemplated
by the Registration Statement. The Registrant did not print or distribute any
preliminary prospectuses, nor has the Registrant actively offered or sold any
securities under the Registration Statement and all activity in pursuit of the
public offering has been discontinued.
Accordingly, we request an order granting the withdrawal of the
Registration Statement be issued by the Commission as soon as possible.
If you have any questions regarding the foregoing application for
withdrawal, please contact Karen Dempsey, outside counsel of the Registrant, at
(415) 947-2014.
Sincerely,
THERASENSE, INC.
/s/ Charlie Liamos
Charlie Liamos
Chief Financial Officer
